Can an end-to-end tele-sepsis solution improve SEP-1 metrics?

November 3, 2022

Many sepsis cases are difficult to detect in a timely manner and these delays impact outcomes. The organization developed an end-to-end sepsis solution, incorporating early detection, automated monitoring, nurse navigators, sepsis consultation, and data collection, and analyzed the impact of their SEP-1 compliance. During an 11-week intervention period, 20,218 patients met initial screening criteria; 1,233 were classified as primary sepsis; 820 contacts to the clinical staff were made; and 73 consults were performed. Compared to institutional baseline, SEP-1 compliance improved during the intervention period (66.5% vs. 78.3%, respectively; p=.0016). The organizations results demonstrate that an end-to-end sepsis solution can improve sepsis metrics. Having Thomas Jefferson share their journey as well as lessons learned will help other members by having concrete tips that they can walk away with and implement in their organizations to see similar outcomes/improvements.


Target Audience



Healthcare Executives

Quality Improvement professionals


Learning Objectives

  • Identify the heterogeneous challenges of optimizing sepsis care
  • Discuss the importance of early screening for potential sepsis patients in optimal capture of an institution's sepsis cases
  • Identify the systems utilized in our end-to-end sepsis solution to significantly improve SEP-1 metric compliance
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 General CE - Attendance
Course opens: 
Course expires: 
Event starts: 
11/03/2022 - 2:00pm CDT
Event ends: 
11/03/2022 - 3:00pm CDT


David Gaieski, MD
Professor of Emergency Medicine
Thomas Jefferson University


Planning committee

Shannon Hale, RN, MHA, CPHQ
Performance Improvement Program Director
Vizient, Inc.

David Gaieski, MD
Professor of Emergency Medicine
Thomas Jefferson University

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.


Disclosure of Financial Relationships:

Relevant Financial Relationships 

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

David Gaieski, MD, speaker and planner for this educational activity, is consultant for Patchd and a clinical and scientific advisor for Insta-Diagnostics.

All relevant financial relationships listed for these individual(s) have been mitigated.

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


Statement of content validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.


FDA off-label/unapproved usage

Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.

Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Designation Statement(s):


This activity is designated for 1.00 contact hours.



Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 General CE - Attendance
Please login or register to take this course.